Literature DB >> 30738982

Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.

Astrid Subrizi1, Eva M Del Amo2, Viktor Korzhikov-Vlakh3, Tatiana Tennikova3, Marika Ruponen4, Arto Urtti5.   

Abstract

Ocular drugs are usually delivered locally to the eye. Required drug loading, release rate, and ocular retention time of drug delivery systems depend on the potency, bioavailability, and clearance of the drug at the target site. Drug-loading capacity of the formulation is limited by the material properties and size constraints of the eye. The design aid described herein for ocular drug delivery systems guides the calculation of steady-state drug concentrations in the ocular compartments, taking into account drug dose, bioavailability, and clearance. The dosing rate can be adjusted to reach the target drug concentrations, thereby guiding the design of drug delivery systems for topical, intravitreal, and subconjunctival administration. The simple design aid can be used at early stages of drug development by investigators without expertise in pharmacokinetic and pharmacodynamic modeling.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Mesh:

Substances:

Year:  2019        PMID: 30738982     DOI: 10.1016/j.drudis.2019.02.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  22 in total

1.  HDL nanoparticles have wound healing and anti-inflammatory properties and can topically deliver miRNAs.

Authors:  Junyi Wang; Andrea E Calvert; Nihal Kaplan; Kaylin M McMahon; Wending Yang; Kurt Q Lu; Han Peng; C Shad Thaxton; Robert M Lavker
Journal:  Adv Ther (Weinh)       Date:  2020-09-30

Review 2.  Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.

Authors:  Md Habban Akhter; Irfan Ahmad; Mohammad Y Alshahrani; Alhanouf I Al-Harbi; Habibullah Khalilullah; Obaid Afzal; Abdulmalik S A Altamimi; Shehla Nasar Mir Najib Ullah; Abhijeet Ojha; Shahid Karim
Journal:  Gels       Date:  2022-01-28

3.  Light-responsive biomaterials for ocular drug delivery.

Authors:  Hend A M Abdelmohsen; Nikki A Copeland; John G Hardy
Journal:  Drug Deliv Transl Res       Date:  2022-06-24       Impact factor: 4.617

4.  Ionic Liquid Pilocarpine Analog as an Antiglaucoma Drug Candidate.

Authors:  Juan Wang; Boxuan Li; Jing Tang; Li Qiu; Xin Qiao; Na Xu; Hu Yang
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-08

5.  Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.

Authors:  Tejabhiram Yadavalli; Joshua Ames; David Wu; Benjamin Ramirez; Navya Bellamkonda; Deepak Shukla
Journal:  Eur J Pharm Biopharm       Date:  2022-03-21       Impact factor: 5.589

Review 6.  Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design.

Authors:  Onyinye J Uwaezuoke; Pradeep Kumar; Viness Pillay; Yahya E Choonara
Journal:  Drug Deliv Transl Res       Date:  2021-01-16       Impact factor: 4.617

Review 7.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24

8.  Effect of Poly(L-lysine) and Heparin Coatings on the Surface of Polyester-Based Particles on Prednisolone Release and Biocompatibility.

Authors:  Abdelrahman Mohamed; Viktor Korzhikov-Vlakh; Nan Zhang; André Said; Iuliia Pilipenko; Monika Schäfer-Korting; Christian Zoschke; Tatiana Tennikova
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

9.  Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.

Authors:  Soohyun Kim; Jennifer J Kang-Mieler; Wenqiang Liu; Zhe Wang; Glenn Yiu; Leandro B C Teixeira; William F Mieler; Sara M Thomasy
Journal:  Transl Vis Sci Technol       Date:  2020-02-27       Impact factor: 3.283

10.  In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation.

Authors:  Blanca Lorenzo-Veiga; Patricia Diaz-Rodriguez; Carmen Alvarez-Lorenzo; Thorsteinn Loftsson; Hakon Hrafn Sigurdsson
Journal:  Nanomaterials (Basel)       Date:  2020-04-09       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.